[
  {
    "ts": null,
    "headline": "Analysts consider potential Qiagen deal amid reported strategic review",
    "summary": "Investing.com -- Shares of Qiagen NV (NYSE:QGEN) surged 16% this week after a Bloomberg report on Tuesday said the company was exploring a potential sale amid renewed interest from several global strategic buyers. The news sparked an immediate rally in the stock, as investors priced in a long-awaited consolidation. Analysts across Wall Street weighed in on the potential sale of the mid-cap diagnostics firm, following years of speculation about its future. Following the news, JPMorgan analyst Cas",
    "url": "https://finnhub.io/api/news?id=3ce525426bcb6c73411553e31da5b7f74d1bbc32ce12bd58483f8d189b158a94",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769203201,
      "headline": "Analysts consider potential Qiagen deal amid reported strategic review",
      "id": 138229361,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "Investing.com -- Shares of Qiagen NV (NYSE:QGEN) surged 16% this week after a Bloomberg report on Tuesday said the company was exploring a potential sale amid renewed interest from several global strategic buyers. The news sparked an immediate rally in the stock, as investors priced in a long-awaited consolidation. Analysts across Wall Street weighed in on the potential sale of the mid-cap diagnostics firm, following years of speculation about its future. Following the news, JPMorgan analyst Cas",
      "url": "https://finnhub.io/api/news?id=3ce525426bcb6c73411553e31da5b7f74d1bbc32ce12bd58483f8d189b158a94"
    }
  },
  {
    "ts": null,
    "headline": "Cramer’s week ahead: Earnings from Meta, Microsoft and Apple. Plus, a Fed meeting",
    "summary": "Cramer on Friday also named which stocks investors should consider buying after earnings.",
    "url": "https://finnhub.io/api/news?id=c59ce71c1eeed600c3f34b51128db326f587914f96142bdb89ab4899ce971864",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769194200,
      "headline": "Cramer’s week ahead: Earnings from Meta, Microsoft and Apple. Plus, a Fed meeting",
      "id": 138246442,
      "image": "https://image.cnbcfm.com/api/v1/image/107113452-NUP_198430_00216r.jpg?v=1697496575&w=1920&h=1080",
      "related": "DHR",
      "source": "CNBC",
      "summary": "Cramer on Friday also named which stocks investors should consider buying after earnings. ",
      "url": "https://finnhub.io/api/news?id=c59ce71c1eeed600c3f34b51128db326f587914f96142bdb89ab4899ce971864"
    }
  },
  {
    "ts": null,
    "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of Jan 25",
    "summary": "A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read the full list here.",
    "url": "https://finnhub.io/api/news?id=51cad26e98a55cff634e728377ee94ee04cf1e5384eb442f6922079bdc07e397",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769191913,
      "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of Jan 25",
      "id": 138229764,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
      "related": "DHR",
      "source": "SeekingAlpha",
      "summary": "A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read the full list here.",
      "url": "https://finnhub.io/api/news?id=51cad26e98a55cff634e728377ee94ee04cf1e5384eb442f6922079bdc07e397"
    }
  },
  {
    "ts": null,
    "headline": "Danaher Corp. stock underperforms Friday when compared to competitors",
    "summary": "Danaher Corp. stock underperforms Friday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=e39609ee8244da01fb659548d13e74e8f3c8775d459f46269f042fe80df49d7c",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769186100,
      "headline": "Danaher Corp. stock underperforms Friday when compared to competitors",
      "id": 138235029,
      "image": "",
      "related": "DHR",
      "source": "MarketWatch",
      "summary": "Danaher Corp. stock underperforms Friday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=e39609ee8244da01fb659548d13e74e8f3c8775d459f46269f042fe80df49d7c"
    }
  },
  {
    "ts": null,
    "headline": "Insights Into Danaher (DHR) Q4: Wall Street Projections for Key Metrics",
    "summary": "Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Danaher (DHR), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2025.",
    "url": "https://finnhub.io/api/news?id=b0788271202dd8ff2f06212438a6747f8397afe1cebb4230c4c1fa63b1eeacf1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769177709,
      "headline": "Insights Into Danaher (DHR) Q4: Wall Street Projections for Key Metrics",
      "id": 138225732,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Danaher (DHR), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2025.",
      "url": "https://finnhub.io/api/news?id=b0788271202dd8ff2f06212438a6747f8397afe1cebb4230c4c1fa63b1eeacf1"
    }
  },
  {
    "ts": null,
    "headline": "Danaher Gears Up to Post Q4 Earnings: What Lies Ahead for the Stock?",
    "summary": "DHR is set to report Q4 results on Jan. 28, with revenues seen up 3.9% and bioprocessing and diagnostics strength in focus.",
    "url": "https://finnhub.io/api/news?id=015ef82ae6a5731f64c42bb00406740b2e7c4c218476d1e027f01fa256f17d6d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769176080,
      "headline": "Danaher Gears Up to Post Q4 Earnings: What Lies Ahead for the Stock?",
      "id": 138225733,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "DHR is set to report Q4 results on Jan. 28, with revenues seen up 3.9% and bioprocessing and diagnostics strength in focus.",
      "url": "https://finnhub.io/api/news?id=015ef82ae6a5731f64c42bb00406740b2e7c4c218476d1e027f01fa256f17d6d"
    }
  },
  {
    "ts": null,
    "headline": "Can Specialty Diagnostics Strength Drive Thermo Fisher's Q4 Earnings?",
    "summary": "TMO heads into Q4 earnings with Specialty Diagnostics growth, fresh FDA approvals and launches that could lift results on Jan. 29.",
    "url": "https://finnhub.io/api/news?id=ac755a74b98ca9bd6d2503866d0b5e23713dd9aee1a03cc3b56a1a81fa8e3c28",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769170620,
      "headline": "Can Specialty Diagnostics Strength Drive Thermo Fisher's Q4 Earnings?",
      "id": 138224810,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "TMO heads into Q4 earnings with Specialty Diagnostics growth, fresh FDA approvals and launches that could lift results on Jan. 29.",
      "url": "https://finnhub.io/api/news?id=ac755a74b98ca9bd6d2503866d0b5e23713dd9aee1a03cc3b56a1a81fa8e3c28"
    }
  }
]